Navigation Links
Aspirin at Bedtime Lowers Blood Pressure
Date:5/14/2008

No benefit seen for prehypertensive people in morning use, researchers report

WEDNESDAY, May 14 (HealthDay News) -- A daily aspirin can control prehypertension, but only if it is taken at bedtime, a Spanish study shows.

An aspirin taken every morning didn't lower the blood pressure of prehypertensive people, but the evening regimen did, Dr. Ramon C. Hermida reported Wednesday at the American Society of Hypertension annual meeting, in New Orleans.

A previous study by Hermida, who is director of bioengineering and chronobiology at the University of Vigo, showed the same beneficial effect of bedtime aspirin for people with moderately high blood pressure. The new report is the first study to show the drug's benefit -- although only when taken at night -- with prehypertension, defined as blood pressure just below the 140/90 level. Prehypertension is a known warning sign of future risk of heart disease, stroke and other cardiovascular problems.

Why aspirin should do its good work for blood pressure at night but not in the daytime is not clear, Hermida said. Research indicates that it can slow the production of hormones and other substances in the body that cause clotting, many of which are produced while the body is at rest.

The three-month study included 244 adults diagnosed with prehypertension. A third of them were advised to follow general rules of hygiene and diet designed to reduce blood pressure, another third were told to take a 100-milligram aspirin tablet every night at bedtime, and the final third were told to take the same aspirin dose on awakening.

Researchers monitored blood pressure levels at 20-minute intervals from 7 a.m. to 11 p.m. and at 30-minute intervals at night before the trial began and three months later.

Systolic blood pressure (the higher number in the 140/90 reading) dropped 5.4 points and diastolic pressure by 3.4 points for those taking aspirin before bedtime. No drop in blood pressure was found in those taking morning aspirin or following the general guidelines.

"There is some evidence that taking a variety of medications, including those for hypertension, at night is associated with greater blood pressure reduction than taking them in the morning," said Dr. Suzanne Oparil, president of the American Society for Hypertension. "I don't think we know why."

It's possible that there might be better absorption of the medication by the gastrointestinal tract at night, said Oparil, who is a professor of medicine at the University of Alabama at Birmingham.

"It's all a little bit speculative about why, but I think the observation is solid," she said.

In a statement, Hermida said the new findings "show us that we cannot underestimate the impact of the body's circadian rhythms."

"The beneficial effects of time-dependent administration of aspirin have until now been largely unknown in people with prehypertension," he said. "Personalizing treatment according to one's own rhythms gives us a new option to optimize blood pressure control and reduce the risk of cardiovascular disease down the line."

More information

Aspirin in all its aspects is described by the U.S. National Library of Medicine.



SOURCES: Suzanne Oparil, M.D., professor, medicine, University of Alabama at Birmingham; May 14, 2008, presentation, American Society of Hypertension annual meeting, New Orleans


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Discovery Health CME Explores the Benefits and Risks of Aspirin in Aspirin Therapy: Maximizing the Benefits
2. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
3. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
4. New, No-Swallow Fasprin(R) Reduces Problems Associated with Daily Aspirin Regimen
5. Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients
6. Aspirin Resistance Boosts Heart Risks in Cardiac Patients
7. Regular, long-term aspirin use reduces risk of colorectal cancer
8. Many stroke, heart attack patients may not benefit from aspirin
9. Women are treated less frequently than men with statins, aspirin and beta-blockers
10. Drugs like aspirin could reduce breast cancer and help existing sufferers
11. Corgenix to Exhibit AspirinWorks(R) Test at 2008 ACOFP Meeting in Denver
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aspirin at Bedtime Lowers Blood Pressure
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, ... relay – Miles by Moonlight to raise money for the American Heart Association Heart ... , Teams will work together to keep their treadmills moving for 5 hours. ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... latest in wound care advancements to physician colleagues, skilled nursing facility medical directors ... "Navigating the Treacherous Waters of Wound Care." , "At many of these conferences ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
Breaking Medicine Technology: